FundingWatcher
Home / Startups / Top health care startups / Health care startups that raised Series B / Health care startups that raised Series B in Cambridge, Massachusetts

Health care startups that raised Series B in Cambridge, Massachusetts

Updated 16 Nov 2026

Reset
Health care startups that raised Series B in Cambridge, Massachusetts
One-time CSV
  • 75 funded companies, 71 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-health-care--series-b~cambridge-massachusetts.csv75 rows × 18 columns
CompanyCityLast roundAmountDate
UltraSightCambridgeSeries B$24.0M2026-09-23
SimnovaCambridgeSeries B$59.3M2026-08-18
KytopenCambridgeSeries B$1.6M2026-04-07
Atavistik BioCambridgeSeries B$40.0M2026-03-05
Nocion TherapeuticsCambridgeSeries B$23.0M2026-01-07
PineTree TherapeuticsCambridgeSeries B$47.0M2025-10-28
ARTBIOCambridgeSeries B$132.0M2025-07-29
Epicore BiosystemsCambridgeSeries B$6.0M2025-05-01

8 rows of the CSV in 5 of its 18 columns.

75
Startups
$8.2B
Total raised
11
Funded in the last 12 months
$696.4M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

11 of 75
11 rows
Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
UltraSight UltraSight applies machine learning to ultrasound to support more accurate and timely clinical decisions. Health care Series B $24.0M 2026-09-23 $39.0M Yozma Group 11 to 50 2018
Simnova Simnova Biotherapeutics develops CAR-based cell therapies for treating cancer. Biotech Series B $59.3M 2026-08-18 $87.2M Oriza Seed Capital (Oriza Yuandian), Youshan Capital, PagodaTree Partners +1 51 to 100 2019
Kytopen Kytopen develops genome engineering platforms for cell therapy research and manufacturing. Biotech Series B $1.6M 2026-04-07 $39.1M National Science Foundation, MassVentures, Alexandria Venture Investments +1 11 to 50 2017
Atavistik Bio Atavistik Bio develops precision allosteric small molecules to treat metabolic diseases and cancer. Biotech Series B $40.0M 2026-03-05 $260.0M Lux Capital, The Column Group, Nextech Invest 11 to 50 2021
Nocion Therapeutics Nocion Therapeutics develops pharmaceuticals to treat conditions arising from neurogenic inflammation. Biotech Series B $23.0M 2026-01-07 $134.0M Canaan Partners, F-Prime, OUP (Osage University Partners) +2 11 to 50 2017
Epicore Biosystems Epicore Biosystems develops sweat-sensing wearables that deliver personalized health insights. Hardware Series B $6.0M 2025-05-01 $41.9M Alumni Ventures, National Institutes of Health, Joyance Partners +1 11 to 50 2017
AIRNA AIRNA develops RNA editing technologies to create medicines for various diseases. Biotech Series B $155.0M 2025-04-01 $245.0M ARCH Venture Partners, Alexandria Venture Investments, Forbion Capital Partners +2 51 to 100 2021
NextPoint Therapeutics NextPoint Therapeutics develops therapeutics to treat cancer patients as a clinical-stage biotechnology company. Biotech Series B $42.5M 2024-02-14 $122.5M Invus, Leaps by Bayer, Catalio Capital Management +2 51 to 100 2020
ROME Therapeutics ROME Therapeutics develops therapies for cancer and autoimmune diseases by targeting the repeatome. Biotech Series B $72.0M 2023-09-12 $199.0M Andreessen Horowitz, Google Ventures, Alexandria Venture Investments +2 11 to 50 2020
InsideTracker InsideTracker provides a platform that analyzes and tracks key biochemical and physiological markers. Biotech Series B $15.0M 2022-09-06 $18.2M OurCrowd, MassVentures, Puget Sound Venture Club +2 11 to 50 2009
Empatica Empatica develops affective computing technology and human data analytics. Artificial intelligence Series B $25.9M 2022-08-02 $35.6M Bossa Invest, Endeavor Catalyst, RA Capital Management +2 101 to 250 2011

Table 1. Health care startups that raised Series B in Cambridge, Massachusetts: the 11 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 75.

Largest rounds

Last 12 months
# Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
1 Simnova Simnova Biotherapeutics develops CAR-based cell therapies for treating cancer. Biotech Series B $59.3M 2026-08-18 $87.2M Oriza Seed Capital (Oriza Yuandian), Youshan Capital, PagodaTree Partners +1 51 to 100 2019
2 Atavistik Bio Atavistik Bio develops precision allosteric small molecules to treat metabolic diseases and cancer. Biotech Series B $40.0M 2026-03-05 $260.0M Lux Capital, The Column Group, Nextech Invest 11 to 50 2021
3 UltraSight UltraSight applies machine learning to ultrasound to support more accurate and timely clinical decisions. Health care Series B $24.0M 2026-09-23 $39.0M Yozma Group 11 to 50 2018
4 Nocion Therapeutics Nocion Therapeutics develops pharmaceuticals to treat conditions arising from neurogenic inflammation. Biotech Series B $23.0M 2026-01-07 $134.0M Canaan Partners, F-Prime, OUP (Osage University Partners) +2 11 to 50 2017
5 Kytopen Kytopen develops genome engineering platforms for cell therapy research and manufacturing. Biotech Series B $1.6M 2026-04-07 $39.1M National Science Foundation, MassVentures, Alexandria Venture Investments +1 11 to 50 2017

Table 2. Health care startups that raised Series B in Cambridge, Massachusetts: the 5 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Alexandria Venture Investments Venture capital firm Pasadena, United States 3 4% 1 Kytopen
2 MassVentures Venture capital firm Boston, United States 2 3% 1 Kytopen
3 Lux Capital Venture capital firm New York, United States 2 3% 1 Atavistik Bio
4 F-Prime Venture capital firm Cambridge, United States 2 3% 1 Nocion Therapeutics
5 ARCH Venture Partners Venture capital firm Chicago, United States 2 3%
6 RA Capital Management Startup incubator Boston, United States 2 3%
7 Andreessen Horowitz Venture capital firm Menlo Park, United States 2 3%
8 Casdin Capital Venture capital firm New York, United States 2 3%
9 Yozma Group Government investment office Tel Aviv, Israel 1 1% 1 UltraSight
10 PagodaTree Partners Private equity firm Beijing, China 1 1% 1 Simnova
11 Guochuang Qinzhi Venture capital firm 1 1% 1 Simnova
12 Oriza Seed Capital (Oriza Yuandian) Venture capital firm Suzhou, China 1 1% 1 Simnova
13 Youshan Capital Private equity firm Beijing, China 1 1% 1 Simnova
14 The Engine Venture capital firm Cambridge, United States 1 1% 1 Kytopen
15 National Science Foundation Entrepreneurship program Alexandria, United States 1 1% 1 Kytopen

Table 3. Health care startups that raised Series B in Cambridge, Massachusetts: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Biotech 66 88% $7.8B
Software 7 9% $513.3M
Hardware 3 4% $112.3M
Artificial intelligence 3 4% $401.8M

Table 4. Health care startups that raised Series B in Cambridge, Massachusetts by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series B 75 100% $42.5M

Table 5. Health care startups that raised Series B in Cambridge, Massachusetts by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
October 2026 1 9% $150.0M
September 2026 1 9% $24.0M
August 2026 1 9% $59.3M
June 2026 2 18% $161.5M
May 2026 1 9% $122.0M
April 2026 1 9% $1.6M
March 2026 2 18% $117.0M
January 2026 2 18% $61.0M

Table 6. Health care startups that raised Series B in Cambridge, Massachusetts: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 11 15% $696.4M
2025 6 8% $543.0M
2024 3 4% $162.5M
2023 10 13% $862.0M
2022 6 8% $412.9M
2021 8 11% $946.0M

Table 7. Health care startups that raised Series B in Cambridge, Massachusetts by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 2 3%
2020 to 2022 15 20%
2015 to 2019 30 40%
2010 to 2014 12 16%
Before 2010 16 21%

Table 8. Health care startups that raised Series B in Cambridge, Massachusetts by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 8 11%
11 to 50 41 55%
51 to 100 18 24%
101 to 250 5 7%
251 to 500 1 1%
10,001 or more 1 1%

Table 9. Health care startups that raised Series B in Cambridge, Massachusetts by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many health care startups in Cambridge, Massachusetts whose last round is Series B are on the list?
75, in the file dated 16 November 2026. 11 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 75 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Health care startups that raised Series B in Cambridge, Massachusetts: 75 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Health care at other stages in Cambridge

Other sectors that raised Series B in Cambridge

Cite: FundingWatcher, 75 health care companies in Cambridge, Massachusetts whose most recent round is Series B, 16 November 2026. https://fundingwatcher.com/startups/health-care/series-b/cambridge-massachusetts/